The PMPRB is a federal quasi-judicial agency with a mandate to ensure that the
ex-factory prices of patented medicines sold in Canada are not excessive. The
PMPRB exercises its mandate through the provisions of legislation, regulations
and guidelines that limit the introductory prices of new patented medicines and
restrict price increases for existing patented medicines. The PMPRB has the
powers of a superior court and can order price reductions and repayment of
excess revenues.
Unparalleled PMPRB expertise - The extent of our PMPRB experience exceeds that of any other consulting firm.
The PDCI Market Access team includes several former senior PMPRB staff members. Our clients
include most of Canada’s leading innovative pharmaceutical companies, bio
pharmaceutical firms and industry associations.
Pricing Strategies for Canada
PDCI Market Access provides an effective pricing strategy as part of the Canadian marketing
plan. We provide assistance in the following areas:
Defining pricing objectives
Identifying government regulations and policies impacting on pricing and
reimbursement and developing strategies
Competitor pricing analysis
Patented Medicine Prices Review Board (PMPRB)
PDCI Market Access offers a complete range of PMPRB-related consulting services:
Strategies & Submissions-
PDCI Market Access assembles and reviews the
relevant information for each case, identifies the issues in the context
of the Board’s Guidelines and develops effective strategies for optimizing
pricing opportunities within the context of the PMPRB Guidelines.
PDCI Market Access will prepare, verify and
file all PMPRB reporting forms and submissions. If necessary, PDCI Market Access can
supply the necessary international prices (as required by the PMPRB
Regulations) for filing with the PMPRB.
Representation & Negotiation -
PDCI Market Access will represent the client
before Board staff for specific pricing or compliance issues, or, on an
ongoing basis for all aspects of the client’s dealings with the PMPRB. PDCI Market Access provides advice and assistance preparing responses to PMPRB
allegations of excessive pricing or failure to file information.
New Medicines / Price Increases -
PDCI Market Access prepares comprehensive
new medicine submissions in a format and style that clearly and concisely
present the client’s position in the context of the Board’s Guidelines.
PDCI Market Access offers client-tailored
on-site seminars and workshops that allow the client to develop a clear
understanding of the PMPRB, its mandate, policies and excessive price
guidelines.
The PMPRB is a federal quasi-judicial agency with a mandate to ensure that the
ex-factory prices of patented medicines sold in Canada are not excessive. The
PMPRB exercises its mandate through the provisions of legislation, regulations
and guidelines that limit the introductory prices of new patented medicines and
restrict price increases for existing patented medicines. The PMPRB has the
powers of a superior court and can order price reductions and repayment of
excess revenues.